Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes

NCT02373865 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Premature termination due to insufficient patient recruitement..

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Sitagliptin
DRUG: Glimepiride
DRUG: Sitagliptin-Placebo
DRUG: Glimepiride-Placebo

Sponsor

GWT-TUD GmbH